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Objective: Report the case of a patient with Crohn´s disease and ligneous conjunctivitis.
Methods: Interventional case report of a 27-year old female patient, with a 4-year history 
of Crohn´s disease, was seen for right eye conjunctival ulcer after resolved chemical trauma. 
Conjunctival biopsy was performed for histopathology, immunoﬂ  uorescence microscopy, and 
immunohistochemistry testing.
Results: Microbiology tests were negative for bacteria and fungi. PCR was negative for atypical 
mycobacteria and Herpes. Ocular Crohn´s disease, Whipple disease, and amyloidosis were ruled 
out. Immunoﬂ  uorescence microscopy revealed characteristic IgG κ and λ light chain deposits, 
and ﬁ  brin deposition was conﬁ  rmed through Lendrum´s Martius, Scarlet, and Blue technique. 
Endogenous plasminogen levels were normal. Recurrent ulcers did not resolve after treatment 
with inﬂ  iximab, but only after four surgeries, topical steroids, 1% cyclosporine, heparin (5000 
units/ml), and hyaluronidase (1.5 mg/ml). After 9 months of follow-up, nasal symblepharon 
was observed as sequela.
Conclusions: We report the case of a patient with unilateral ligneous conjunctivitis, triggered 
by chemical injury, and Crohn´s disease.
Keywords: Crohn´s disease, immunoﬂ  uorescence microscopy, ligneous conjunctivitis, plas-
minogen, ulcerative conjunctivitis
Introduction
Ligneous conjunctivitis (LC) is a rare form of chronic conjunctivitis characterized by 
the development of ﬁ  brin-rich, woody-like pseudomembraneous tissue in the tarsal 
conjunctiva (Schuster and Seregard 2003). It occurs in association with external irri-
tants and ocular surgery (Schuster and Seregard 2003).
Plasminogen deﬁ  ciency has recently been found to be the most common cause of 
LC, and the lesions are the result of an impaired wound healing response (Schuster and 
Seregard 2003). LC seems to be the most common symptom of this systemic disorder, 
since it usually occurs with other mucosal involvement (Schuster and Seregard 2003).
Crohn´s disease (CD) is an inﬂ  ammatory bowel disease with ocular involvement 
as an extraintestinal manifestation. The eye disease commonly presents as anterior 
uveitis and, rarely, with naevus and conjunctival or lid ulcers (Lendrum et al 1962; 
Schuettenberg 1991; Hegab and al-Mutawa 1994; Zoli et al 1997; Diaz-Valle et al 
2004). Based on clinical evolution and histopathology ﬁ  ndings, we report a rare case 
of a patient with CD and LC triggered by chemical injury.
Case report
A 27-year-old female patient presented at our center with a 6-week history of right eye 
pain and ulceration. The symptoms appeared one month after a resolved conjunctival 
chemical burn with 17% hydrochloric acid. The recurrent corneal and conjunctival Clinical Ophthalmology 2008:2(1) 204
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ulcers progressed despite topical corticosteroids, 1%, 
cyclosporine A (CsA), antibiotics, and artiﬁ  cial tears. 
The patient also had a 4-year history of aggressive CD, 
conﬁ  rmed by intestinal biopsy, which required immuno-
suppressive therapy with azathioprine, anti-TNF-alpha 
treatment, and intestinal resection. Her CD had been stable 
for last 6 months.
Visual acuity was 20/200 for her right eye and 20/20 for 
the left eye. Our initial slit-lamp examination of her right 
eye revealed plaque-like ulcerations in the nasal bulbar 
conjunctiva and in the inferior and superior tarsal conjunctivas 
(Figure 1A, B). The left eye was normal. Systemic workup 
ruled out sarcoidosis, systemic vasculitis, rickettsias, brucella, 
syphilis, chlamydia, Lyme disease, and HIV.
Bulbar, upper, and lower fornix conjunctival resections 
were performed on the affected eye. Tissue specimens from 
the resection were processed for special stains including 
Gram and acridine orange for bacteria, calcoﬂ  uor and peri-
odic acid Schiff (PAS) stains for fungi and/or Whipple dis-
ease, and Congo red for amyloidosis. The presence of atypical 
mycobacteria and Herpes were determined by polymerase 
chain reaction (BIOTOOLS B and M Labs, Madrid, Spain). 
All of the tests were negative.
Tissue sections for routine histopathological examination 
were stained with hematoxylin and eosin (H&E) and PAS stains. 
Fibrin deposits were assessed by Lendrum´s Martius, Scarlet, 
and Bluetechnique (MSB) technique (Lendrum et al 1962).
Immunoﬂ  uorescence microscopy for IgG and κ, λ light 
chain deposits was performed with polyclonal antihuman 
antibodies from BioGenex Laboratories (San Ramon, 
CA, USA) and DAKO Corp. (Carpintería, CA, USA), 
respectively. The secondary antibody was FITC-conjugated 
anti-rabbit IgG (Sigma, St. Louis, MO, USA).
Histopathology reported surface ulcerations with 
an underlying thick band of hyaline-like eosinophilic 
material, granulation tissue, and lymphocytic inﬁ  ltration 
(Figure 2A). Abundant ﬁ  brin deposition was conﬁ  rmed 
with the MSB technique (Figure 2B). No granulomas were 
found. Histopathology and IF ﬁ  ndings were compatible 
with LC. Her systemic plasminogen values were tested and 
“verbally reported” within normal limits (0.7–1.0 U/ml), on 
two separate occasions.
After the conjunctival resection, her symptoms and signs 
resolved, but then recurred two weeks later (Figure 1C). Her 
gastroenterologist indicated treatment with 3 doses of inﬂ  ix-
imab (5 mg/kg/day, Remicade, Schering-Plough, Kenilworth, 
NJ), but ocular signs did not improve. A second surgical 
excision was performed and treatment with 1% CsA three 
times a day (tid) initiated.
Three weeks later, a third excision was performed, since 
the lesion recurred, became very painful, and progressed 
toward the inferior palpebral skin. Otorrhinolaryngology 
evaluation was solicited and reported as normal.
Topical heparin (5000 units/ml) tid and ﬂ  uorometho-
lone tid was added. Due to further progression, a fourth 
excision was performed one month later, and topical 
hyaluronidase (1.5 mg/ml) tid added. Six months after 
treatment, the lesions resolved but an inferior nasal sym-
blepharon developed as sequela, after a 9-month follow-up. 
(Figure 1D).
Figure 1 Initial right eye slit-lamp examination. The nasal bulbar and inferior conjunctivas (A) and the superior tarsal conjunctiva (B) had plaque-like ulcerations. The initial 
conjunctival ulceration was followed by a recurrence of the inferior tarsal ulcer (C). A nasal symblepharon remained as a sequela after a 9-month followup (D).Clinical Ophthalmology 2008:2(1) 205
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Discussion
Ocular involvement, as an extraintestinal manifestations 
of inﬂ  ammatory bowel disease, occurs in less than 12% of 
cases (Ghanchi and Rembacken 2003). It manifests as uveitis, 
episcleritis, scleritis, nonspeciﬁ  c follicular conjunctivitis, lid 
marginal ulcers, during active or inactive disease (Salmon 
et al 1991; Schuettenberg 1991; Hegab and al-Mutawa 1994; 
Zoli et al 1997; Ghanchi and Rembacken 2003; Diaz-Valle 
et al 2004). She had been asymptomatic for over one year 
with no treatment and remained as such throughout her 
ocular disease.
Previously reported cases of lid margin and conjunctival 
ulcers in CD have resolved after systemic and topical corti-
costeroid treatment (Hegab and al-Mutawa 1994; Diaz-Valle 
et al 2004). We initially believed these conjunctival ulcers 
were due to her CD, which is why inﬂ  iximab therapy was 
administered, after consulting with her gastroenterologist, 
however she did not respond. In addition, histopathology 
ﬁ  ndings were more compatible with LC, since no granulomas 
were reported, which could have been triggered by previous 
chemical injury (Schuster and Seregard 2003).
LC is a rare disease, with a prevalence of 1.6 per million 
in Europe, and due to the inheritance of an autosomal reces-
sive gene (Schuster and Seregard 2003). It involves a great 
variety of systemic manifestations including periodontitis, 
renal calculi, vulvovaginitis, respiratory disease, otitis media, 
dermatologic lesions, and hydrocephalus, among others 
(Schuster and Seregard 2003). Our patient did not report any 
of these systemic manifestations other than an ocular chemi-
cal burn one month before the lesions appeared.
LC patients may have decreased levels of plasminogen, 
which arrests wound healing at the granulation tissue 
formation stage, and subsequently forms a fibrin-rich 
pseudomembranous tissue (Schuster and Seregard 2003). 
However, normal serum plasminogen levels do not exclude 
LC because it is not a diagnostic criterion, but a predisposing 
factor, as would be in this case.
Other triggers for the development of LC include expo-
sure to chemical irritants and conjunctival surgery (Schuster 
and Seregard 2003). In this patient, exposure to chemical 
irritants could have triggered the LC, which recurred after 
multiple surgical interventions.
This patient’s conjunctival ulcers healed after topical 
CsA, heparin, and hyaluronidase therapy, which have 
been reported as effective treatments for LC (Schuster and 
Seregard 2003).
The fact that conjunctival cicatrizing sequela is not 
characteristic of LC also challenged our initial diagnosis, 
although corneal scarring has been reported as a LC sequela, 
however the previous chemical burn strongly supported this 
diagnosis (Hidayat and Riddle 1987).
Histopathologically, LC is characterized by subepithelial, 
eosinophilic, amorphous material admixed with acute 
and chronic inflammatory cells, positive PAS staining, 
and negative Congo red staining (Hidayat and Riddle 
1987; Holland et al 1989; Klebe et al 1999). In this case 
histopathology ﬁ  ndings, abundant ﬁ  brin deposition, chronic 
inflammation with granulation tissue and lymphocytes, 
absence of granulomas, and negative Congo red staining, 
coincided with LC (Hidayat and Riddle 1987; Holland et al 
1989; Klebe et al 1999; Schuster and Seregard 2003).
Given the history of her immunobiological disease, 
triggering chemical burn, clinical progression despite inﬂ  iximab 
therapy, characteristic histopathology, multiple recurrences, 
and resolution after combined surgical and topical treatments, 
LC was our ﬁ  nal diagnosis. The LC in this CD patient was 
refractory to conventional treatments, however the coexistence 
between both diseases can be considered as casual.
We present a rare case of LC, triggered by conjunctival 
chemical injury, casually coexisting in a patient with CD.
Figure 2 Histopathology of conjunctival biopsies. The superﬁ  cial ulceration had an underlying thick band of hyaline-like eosinophilic material, probably composed of ﬁ  brin 
(arrow). Granulation tissue and lymphocytic inﬁ  ltration were apparent in H&E (A) and ﬁ  brin (arrow) was conﬁ  rmed with Lendrum staining (B). The tissue sample was 
negative for Congo red.Clinical Ophthalmology 2008:2(1) 206
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